MedPath

HYDROXYZINE PAMOATE

Hydroxyzine Pamoate 50mg

Approved
Approval ID

a5008eba-91a4-cb2f-e053-2a95a90a869e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 1, 2020

Manufacturers
FDA

RedPharm Drug, Inc.

DUNS: 828374897

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HYDROXYZINE PAMOATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-1098
Application NumberANDA201507
Product Classification
M
Marketing Category
C73584
G
Generic Name
HYDROXYZINE PAMOATE
Product Specifications
Route of AdministrationORAL
Effective DateMay 1, 2020
FDA Product Classification

INGREDIENTS (10)

HYDROXYZINE PAMOATEActive
Quantity: 50 mg in 1 1
Code: M20215MUFR
Classification: ACTIR
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HYDROXYZINE PAMOATE - FDA Drug Approval Details